Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00662896 · ClinicalTrials.gov registry record · Phase 1
To Assess the Effect of Naproxcinod Versus Naproxen and Ibuprofen on Arterial Blood Pressure in Osteoarthritis Patients With Controlled Essential Hypertension
A Phase 1 study, sponsored by NicOx.
- Completed
- Registry status
- Phase 1
- Development phase
- 300
- Enrollment target
NCT00662896: Completed Phase 1 study, sponsored by NicOx.
NCT00662896 is a Phase 1 study that has completed, run by NicOx. The registered enrollment target is 300 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (400% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00662896, a Phase 1 study, has completed, sponsored by NicOx.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 300 participants
- Enrollment target
Study Summary
To assess the effect of naproxcinod vs. naproxen and ibuprofen on arterial blood pressure in patients with osteoarthritis and controlled essential hypertension
Interventions
- DRUG naproxcinod 375 mg bid
- DRUG naproxcinod 750 mg bid
- DRUG naproxen 250 mg bid
- DRUG naproxen 500 mg bid
- DRUG ibuprofen 600 mg tid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2008-03 |
| Est. Completion | 2008-12 |
| Phase | Phase 1 |
What the finished NCT00662896 record still lists
NCT00662896 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (400% higher).
The record links to 0 conditions, and to 5 interventions - of which naproxcinod 375 mg bid is the first listed.
NCT00662896 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00662896 about?
NCT00662896 is a clinical study titled "To Assess the Effect of Naproxcinod Versus Naproxen and Ibuprofen on Arterial Blood Pressure in Osteoarthritis Patients With Controlled Essential Hypertension". To assess the effect of naproxcinod vs. naproxen and ibuprofen on arterial blood pressure in patients with osteoarthritis and controlled essential hypertension
What is the current status of trial NCT00662896?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 300 participants. The study started on 2008-03. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00662896?
The interventions under investigation include: naproxcinod 375 mg bid (DRUG), naproxcinod 750 mg bid (DRUG), naproxen 250 mg bid (DRUG), naproxen 500 mg bid (DRUG), ibuprofen 600 mg tid (DRUG).
Who is sponsoring clinical trial NCT00662896?
This trial is sponsored by NicOx, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00662896's enrollment target sits among peer trials
300 124th of 2000 higher than 1,867 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia